Kappa Bioscience

About us

At Kappa Bioscience we are proud to offer you high purity vitamin K2 as menaquinone-7 (MK-7).  As the innovative leader and first mover of vitamin K2 MK-7, we have extensive knowledge about vitamins and are currently the only vendor with vitamin K2 as pure MK-7 in various formulations. Based on the self-affirmed GRAS approval, our K2 MK-7 can also be used in conventional foods.

Founded in December 2006, Kappa Bioscience is a Norwegian based entity that takes pride in following a traditional vitamin production process with propriety and innovative new steps.  One of our core assets is the patent covering the production of pure vitamin K2 as menaquinone‑7.

Our main focus is to develop vitamin K2 for the food supplement and fortified foods market.

Vitamin K2 is currently gaining momentum across the world and as it does, we intend to continue to serve the market with pure and stable forms of MK-7 products.

All of our products have been developed in close collaboration with highly qualified Norwegian and international scientists, who have been able to successfully accomplish the difficult process of producing menaquinone-7.

We are proud to launch the first man-made menaquinone-7 in its natural form - as K2VITAL®.

  • Our research is conducted globally

  • Production is established in Europe

  • Marketing and sales activities are managed from Germany.


Our Vision

Kappa Bioscience has the vision to deliver vitamin K2 to the mass market, making it available to everybody, everywhere.


Mission statement

We believe our product – Vitamin K2 MK-7 and our mission is to provide everyone from manufacturers to consumers with a pure, reliable and safe product.  We take pride in delivering everyone with a quality product for improving health.


Our values

The company values shall guide each individual employee’s behavior and be the basis for creating a transparent and collaborative company culture.  Kappa Bioscience’s core values are:

Bravery / Openness / Activeness


Egil Greve

President and CEO

Egil is an entrepreneur with broad executive experience from building up companies and business units within the multinational companies Norsk Hydro ASA, Yara International ASA and AKZO Nobel. He also headed several SMBs including NattoPharma ASA before he was asked to build up Kappa Bioscience in 2009.


Kai Schröder

VP Finance & Operations
MSc (Management & Economics), INSEAD EMP

Kai is an executive with experience from international companies such as GE Healthcare, Philip Morris International and Porsche in functions ranging from Manufacturing & Supply Chain to General Management. He accumulated extensive know-how in the areas of Managing P&Ls, Commercial Management and Leadership, Finance and Strategy as well as Sales & Operations Planning.


Trygve Bergeland

VP Science & Product Development

Trygve has a broad experience in research and documentation within the nutraceutical and pharmaceutical industry. Before joining Kappa Bioscience, Trygve was responsible for the clinical documentation program in Aker BioMarine. He has generated extensive experience from management of clinical research in Clavis Pharma and LINK Medical Research.


Inger Reidun F. Aukrust

Vice President R&D & Chemistry
PhD in Organic Chemistry

More than 25 years of experience within medicinal chemistry and custom synthesis from SINTEF and Synthetica. Founder of Synthetica and Kappa Bioscience.


Jörg Büttinghaus

Vice President Sales & Marketing

Jörg is responsible for the groups global sales and marketing organization. He has been a member of the nutraceutical industry for more than 15 years, during which time he was involved in the introduction of several successful specialities including PressCAL®, AlgaeCal®, NEM®, Calcified Atlantic Seaweed® and K2VITAL®.


Jon Erik Brænden

Vice President Production

Jon Erik is responsible for the production, and holds a PhD in organic chemistry. Before joining Kappa Bioscience he has been 25 years in the pharmaceutical industry, responsible for documentation, product and process development of active pharmaceutical ingredients, within the area of contrast agents, cancer, analgesics (opioids) and diabetes. 


Henriette Bastiansen

Vice President Quality & Regulatory
Master in Food Science & Technology

Henriette is responsible of the global quality management and regulatory affairs. She holds a Master’s degree and worked for global companies such as Colgate-Palmolive, Mondelez International, Chr Hansen and Kevin Murphy. She gained a broad experience in developing and implementing regulatory strategies, evaluating the compliance of product content, specifications, labeling and registrations and quality management.



The origin of K2VITAL® dates back to 2006, when Norwegian researcher, Dr Inger Reidun Aukrust, together with her team, discovered a process to produce all-trans Vitamin K2, MK-7, using natural compounds such as geraniol and farnesol in a strictly controlled synthesis process.

The significance of the process for all-trans vitamin K2 MK-7 has been recognised and patented. For vitamin K’s, two stereo chemical versions can exist: cis and trans forms of the molecule. The cis form remains biologically inactive, while the trans form has a full biological potential. Commercially available vitamin K2 products may contain both forms.



Kappa is proud to work and collaborate with the leading nutritional supplements distributors in regions that span the globe. We invite you to contact our distributors directly to learn about K2VITAL® and the Kappa product portfolio, or contact Kappa directly and we will make an introduction.

DistributorCountryRegioOperative in charge
PathwayAustralia and New ZealandAsiaMr Wayne Coote (Email)
PharmachemIndiaAsiaPradeep Anaokar (Email)
ConnellBangladeshAsiaMD. Abul Hasnat (Email)


VietnamAsiaMs. Thi (Pharma) (Email)
Ms. Phoi (Food) (Email)
Epic IngredientsMalaysiaAsiaMr Jeffrey Aw (Email)
Connell BrosTaiwanAsiaMs Irene Hsueh (Email)
PhytonetPhilippinesAsiaMrs Helen Grace Basia (Email)
Velpha ChemicalsPakistanAsia

Mr Ali Hassni (Email)

PhytonetKoreaAsiaMr Allen Lee (Email)
Rama ProductionThailandAsiaMs Prakaithip Ekwongsupasarn (Email)

Shanghai Toong Yeuan Food Tech Ltd.
Shanghai Toong Yeuan Healthcare Tech Ltd.

ChinaAsiaSteven Wang (Email)
PT TatarasaIndonesiaAsiaMr Soekiandi Ali (Email)
Zifroni ChemicalsIsraelMiddle EastRafi Zifroni (Email)
TFS GroupRussiaEurope/ AsiaIlya Okhotin (Email)
FaravelliItalyEuropeTiziana Ferrari (Email)
KUKEastern EuropeEuropeStephan Wohlrab (Email)
PhytonetTurkeyEuropeSelim Ay (Email)
PhytonetSerbiaEuropeBojan Pavlovic (Email)
Safic AlcanSpainEuropeMercedes Carillo (Email)
Safic AlcanFrance + MoroccoEuropeCharlotte Delarue (Email)
KUKBaltic + GreeceEuropeLīga Eglīte​ (Email)
Solo GroupSouth AfricaAfricaDean Hall (Email)
BiochimexAlgeria + TunisiaAfricaChristielle Dupain (Email)
AIDPUSAAmericaMark Thurston (Email)
ChemroyCanada + USAAmericaJim Bornhold (Email)
RJR Nutrientes e Farmoquímicos Ltda.BrazilAmericaFelipe Simões (Email)
Safe Iberoamericana S.A. de C.V.MexicoAmericaJorge Cabeiro (Email)
Deltagen SAS.ColombiaAmericaPaul Agudelo (Email)


  • Company
  • Vitamin K2

Formulation next-generation vitamin k2

More Information

Vitamin manufacturer Kappa acquires European distributor PPM

More Information

Kappa buys European distributor

More Information

Kappa Bioscience Creates End-to-End Solution with Acquisition of ppm.Ingredients

More Information

Kappa Bioscience to Acquire European Distributor ppm.Ingredients

More Information

Kappa Bioscience reveals free vitamin K2 MK-7 quality testing program

More Information

Kappa Bioscience announces vitamin K2 stability project

More Information

New study demonstrates vitamin K2 MK-7 bioequivalence for the two primary manufacturing approaches

More Information

Synthesis-derived MK-7 is Bioequivalent to Fermentation-derived MK-7

More Information

Kappa Bioscience unveils first-in-class vitamin K2 MK-7 formulations book at Vitafoods 2016

More Information

Vitamin K2 MK-7: A stability challenge, a market study

More Information

Unfulfilled Promises: The Need for Ethical K2 Labelling

More Information

Kappa debuts double-coated vitamin K2

More Information

Customer Download Portal

Sign up | Reset password

Sales and Marketing
Kappa Ingredients GmbH
Friesenweg 4 | Building 13 | 22763 Hamburg

Kappa Bioscience AS
Silurveien 2 | Building B | 0380 Oslo

+49 40 6094087 0